Metraipolis › archive › dc_b3bbfd4263dd

Microplanning improves stakeholders' perceived capacity and engagement to implement lymphatic filariasis mass drug administration — Europe PMC PMID:40163546

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/40163546
DOI: 10.1371/journal.pntd.0012105
License (as archived): CC0-1.0
Archived: 2026-10-06T12:00:12.897Z
SHA-256 of the archived text: 51546ebd6c649e62d59c14d1f184f3554a2dc225fb847107c8909c527c7bb6cf
Stable URL of this page: https://metraipolis.com/documento/dc_b3bbfd4263dd

How to cite

Microplanning improves stakeholders' perceived capacity and engagement to implement lymphatic filariasis mass drug administration — Europe PMC PMID:40163546 — Europe PMC (en), https://europepmc.org/article/MED/40163546 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_b3bbfd4263dd (Metraipolis archive dc_b3bbfd4263dd, sha256 51546ebd6c649e62d59c14d1f184f3554a2dc225fb847107c8909c527c7bb6cf)

BibTeX

@misc{dcb3bbfd4263dd,
  title = {Microplanning improves stakeholders' perceived capacity and engagement to implement lymphatic filariasis mass drug administration — Europe PMC PMID:40163546},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40163546},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_b3bbfd4263dd; sha256 51546ebd6c649e62d59c14d1f184f3554a2dc225fb847107c8909c527c7bb6cf},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/40163546. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Background: Achieving adequate mass drug administration (MDA) coverage for lymphatic filariasis is challenging. We sought to improve stakeholder engagement in MDA planning and increase subsequent MDA coverage through a series of microplanning workshops. Methodology: Prior to the 2018 MDA, Haiti's Ministry of Public Health and Population (MSPP) and partners conducted 10 stakeholder microplanning workshops in metropolitan Port-au-Prince. The objectives of the workshops were to identify and address gaps in geographic coverage of supervision areas (SAs); review past MDA performance and propose strategies to improve access to MDA; and review roles and responsibilities of MDA personnel through increased stakeholder engagement. Retrospective pre-testing was employed to assess the effectiveness of the workshops. Participants used a 5-point scale to rank their understanding of past performance, SA boundaries, roles and responsibilities, and their perceived engagement by MSPP. Participants simultaneously ranked their previous year's attitudes and their attitudes about MDA following the 2-day microplanning workshop. Changes in pre- and post-scores were analyzed using Wilcoxon signed-rank tests. Principal findings: A total of 356 stakeholders across five communes participated in the workshops. Participants conducted various planning activities, including revising SA boundaries to ensure full geographic reach of MDA, proposing or validating social mobilization strategies, and proposing other MDA improvements. Compared with previous year rankings, the workshops increased participant understanding of past performance by 1.34 points (standard deviation [SD] = 1.05, p <0.001); SA boundaries by 1.14 points (SD = 1.30; p <0.001); their roles and responsibilities by 0.71 points (SD = 0.95, p <0.001); and sense of engagement by 1.03 points (SD = 1.08, p <0.001). Additionally, compared with 2017, drug coverage increased in all five communes during the 2018 MDA. Conclusions/significance: Participatory stakeholder workshops during MDA planning can increase self-reported engagement of key personnel and may improve staff performance and contribute to achievement of drug coverage targets. Microplanning success was supported by MDA results, with all communes achieving preset MDA coverage targets.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: PLoS neglected tropical diseases, 2025 (prima pubblicazione 2025-03-31).
Identificativi: PMID 40163546 · PMCID PMC11990631 · DOI 10.1371/journal.pntd.0012105.
Descrittori MeSH principali: Elephantiasis, Filarial; Filaricides; Stakeholder Participation; Mass Drug Administration.
Pagina: https://europepmc.org/article/MED/40163546 — https://doi.org/10.1371/journal.pntd.0012105. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-10-06T10:21:17.995Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.